drugset / Trial / NCT01381796

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

NCT01381796

Phase 1 Completed 63 enrolled NuPathe Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this research is to: 1. Compare two study patches having minor differences in patch components 2. Compare the pharmacokinetics (PK - how the body absorbs, metabolizes and eliminates medication) of NP101 (study patches) versus a currently approved oral formulation of Imitrex 3. Collect resistance data during application of NP101 (study patch)

Timeline

Start
2009-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sumatriptan Unknown 100 mg Other

Indications

No indication recorded.